Attention-deficit/Hyperactivity Disorder | CHOP Research Institute
 

Attention-deficit/Hyperactivity Disorder

Published on
Nov 26, 2024
Donna McDonald-McGinn, Director of the 22q and You Center, received a Dedication to Service award for her lifelong 22q11.2 deletion syndrome work.

Dr. Nissley-Tsiopinis aims to improve the quality and implementation of interventions for children and adolescents with attention-deficit/hyperactivity disorder and other children/teens with executive functioning deficits, and to improve access to these interventions for diverse populations.

E-mail:
nissleyj [at] chop.edu
Published on
Jul 22, 2022
Learn about novel findings from our Children’s Hospital of Philadelphia researchers.

The purpose of this study is to understand how motor function- the way we move our faces and bodies- impacts social communication.

The Center for Applied Genomics (CAG) develops new and better ways to diagnose and treat children with genetic disorders, including attention-deficit/hyperactivity disorder, asthm

Dr. Hom has interests in multiple areas of child and adolescent psychiatry such as anxiety, mood, attention-deficit/hyperactivity disorder, and autism.

Stephon N. Proctor, PhD, ABPP,  is clinical child psychologist specializing in the evaluation and treatment of attention-deficit hyperactivity disorder, disruptive behavior disorders, and anxiety disorders.

Dr. Shults works to develop statistical methods for longitudinal data that include semi-parametric approaches to account for subject/cluster level associations and maximum likelihood-based approaches for simulation and analysis of discrete longitudinal outcomes that may have overdispersion.

E-mail:
shultsj [at] chop.edu

The Partnering to Achieve School Success (PASS) Study strives to increase access to services and improve the school success and overall well-being of children with attention-deficit/hyperactivity disorder.

Published on
Sep 25, 2020
In the News this week features concussion diagnosis in athletes, racial genetic differences in ADHD, COVID-19 projections, and more.